Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia

  • Obeid R
  • Herrmann W
  • 123


    Mendeley users who have this article in their library.
  • 244


    Citations of this article.


Mild to moderate hyperhomocysteinemia is a risk factor for neurodegenerative diseases. Human studies suggest that homocysteine (Hcy) plays a role in brain damage, cognitive and memory decline. Numerous studies in recent years investigated the role of Hcy as a cause of brain damage. Hcy itself or folate and vitamin B12 deficiency can cause disturbed methylation and/or redox potentials, thus promoting calcium influx, amyloid and tau protein accumulation, apoptosis, and neuronal death. The Hcy effect may also be mediated by activating the N-methyl-d-aspartate receptor subtype. Numerous neurotoxic effects of Hcy can be blocked by folate, glutamate receptor antagonists, or various antioxidants. This review describes the most important mechanisms of Hcy neurotoxicity and pharmacological agents known to reverse Hcy effects. © 2006 Federation of European Biochemical Societies.

Author-supplied keywords

  • Brain
  • Dementia
  • Folate
  • Homocysteine
  • Oxidative stress
  • Vitamin B12

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • Rima Obeid

  • Wolfgang Herrmann

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free